TheStreet's Biotech Bible: A Compendium of Biotech Companies for Today's Investor

Heard there’s a lot going on in biotech but haven’t had time to look into it? Jim Cramer introduces this one-of-a-kind e-book with solid summaries of all the biotechnology and biopharmaceutical firms that have gone public in the past three years – their leaders, products, ongoing research, and financing. Researched by staff at The Street, TheStreet's Biotech Bible is designed to be a quick, useful source of information on today’s biotechnology industry.